title: Lung function in infants with wheezing and gastroesophageal reflux.
abstract: Eighty-four otherwise healthy infants with daily wheezing underwent infant pulmonary function tests (IPFTs) and 24-h esophageal pH probe studies. Fifty-four (64%) infants had positive pH probe studies, and 30 infants had negative pH probe studies. Many infants in both groups had evidence of peripheral airflow obstruction at tidal breathing and on forced expiration as measured by thoracoabdominal compression. In infants with gastroesophageal reflux (GER), only 9 of 54 (16.6%) responded to bronchodilator therapy compared to 20 of 30 (66.6%) in the group with negative pH probe studies (P < 0.0005). In infants with positive pH studies, family history of asthma (n = 16) correlated well with positive response to bronchodilators (P < 0.0005), and all infants exposed to maternal smoking (n = 11) had no response to bronchodilators. Forty-four percent of infants with a positive pH probe had no gastrointestinal symptoms suggestive of GER. In infants with a negative pH probe, family history of asthma (n = 24) correlated well with positive response to bronchodilators (P < 0.0005), and exposure to maternal smoking (n = 8) correlated well with no response to bronchodilator therapy (P < 0.0005). We conclude that silent GER is common in infants with persistent wheezing. Furthermore, infants with GER are less likely to respond to bronchodilator therapy, and exposure to maternal smoking and family history of asthma may be significant independent factors.
authors.affiliation: Department of Pediatrics, University of Louisville, Kentucky, USA.
authors.forename: S
authors.initials: S
authors.lastname: Sheikh
authors.forename: L J
authors.initials: LJ
authors.lastname: Goldsmith
authors.forename: L
authors.initials: L
authors.lastname: Howell
authors.forename: J
authors.initials: J
authors.lastname: Hamlyn
authors.forename: N
authors.initials: N
authors.lastname: Eid
mesh_terms: D001249:Asthma / Q000235:genetics; D001993:Bronchodilator Agents / Q000627:therapeutic use; D016022:Case-Control Studies; D005260:Female; D005764:Gastroesophageal Reflux / Q000150:complications / Q000503:physiopathology*; D006801:Humans; D006863:Hydrogen-Ion Concentration; D007223:Infant; D008168:Lung / Q000503:physiopathology*; D008297:Male; D008991:Monitoring, Physiologic; D012129:Respiratory Function Tests; D012135:Respiratory Sounds / Q000209:etiology*; D014028:Tobacco Smoke Pollution / Q000009:adverse effects
chemical_list: D001993:Bronchodilator Agents; D014028:Tobacco Smoke Pollution